Repro Med Systems Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -131.6% | – | -8,251.3% | – | -125.3% | – | – | +1,572.5% | -98.7% | +1,373.9% | – | |
| – | +5.7% | +1.3% | -5.8% | +4.6% | -7.2% | +2.8% | -3.6% | -2.4% | -12.4% | +10.2% | +6.3% | – | |
| – | -44.2% | +79.8% | -12.2% | -0.8% | +14.8% | -0.3% | -52.7% | +90.2% | +55.1% | -29.9% | -32.8% | – | |
| – | – | -73.5% | -73.9% | -394.8% | – | -122.2% | – | -71.4% | +4,526.4% | -110.5% | – | – | |
| – | -7.4% | -32.1% | -6.6% | +771.9% | -96.0% | +917.8% | -93.5% | +82.2% | +676.9% | -78.0% | +542.3% | – | |
| – | -2.5% | -36.1% | +11.6% | +642.2% | – | -980.7% | -93.6% | +82.1% | +703.4% | -78.7% | +542.3% | – | |
| – | – | – | – | – | -250.1% | – | – | – | – | – | – | – | |
| – | – | – | – | – | -142.0% | +2.3% | +2.3% | – | -217.8% | -91.9% | +29.2% | – | |
| – | -140.4% | +2.1% | +23.6% | – | -157.6% | -25.5% | +19.4% | – | -166.8% | -89.0% | +306.7% | – | |
| – | – | -193.2% | – | – | – | -209.1% | – | – | -0.3% | -125.6% | – | – | |
| – | – | -153.3% | – | – | – | -169.3% | – | – | +5,196.6% | -110.9% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.